Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

What does the head of the largest diabetes charity in the UK have to say about the future of diabetes prevention, treatment, and research?
Tripling my carbs --> 5 fewer hours in-range per day, 64% more insulin (!), & more lessons learned.
A world-renowned researcher’s seven tips for expectant mothers with type 1, type 2, or gestational diabetes
How to test your receiver to make sure it is working properly.
Adam Brown leads expert panel discussion at The diaTribe Foundation’s first-ever digital health gathering at ADA 2016.
Recruiting participants in Boston at the Joslin Diabetes Center
JDRF and Helmsley Charitable Trust workshop highlights future goals and expectations for glucose-responsive insulin.
Stephen England discusses balancing elite ultramarathon competitions with a full-time job and diabetes
Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
Who is “closing the loop,” and how fast are they moving?
Launches in the next 12-18 months. What we’re excited about…!
What Abbott, Dexcom, LifeScan, Medtronic, Tandem, and others are bringing to make diabetes easier and less burdensome
What helps me feel less frustration, failure, struggle, and guilt.
A standing ovation for Dr. Margaret Powers at ADA last month r Dr. Margaret Powers at ADA last month.
Tighter requirements for home meters. What does this mean for current and future blood glucose monitors?
Why the FDA may change its definition of healthy, and how it could impact people with diabetes. Plus, what's coming to nutrition labels?
ADA statement of support released at the 2 nd Diabetes Surgery Summit; highlights reversal of diabetes symptoms after surgery for some candidates
Dexcom’s new insertion, Android G5, touchscreen receiver; Medtronic’s Android MiniMed Connect, Hypo Prediction App, 670G, and Guardian Connect.
80 days, 5 lbs of weight loss, and my strongest blood glucose numbers ever?
MannKind has re-launched the inhaled mealtime insulin, Afrezza, alongside new initiatives to promote the product

Pages